Recently, reports had been published that several biomarkers such as MGMT, STAT3, and APNG were involved in the TMZ resistance of gliomas (Jacinto and Esteller, 2007; Agnihotri et al., 2012; Lee et al., 2011). This evidence concerns the gene MPG and central nervous system cancer.